The TK Lab Logo

Welcome to the laboratory of Tony Kouzarides
Researching epigenetic modifications and their role in cancer

Welcome to the laboratory of Tony Kouzarides
Researching epigenetic modifications and their role in cancer

Other TK Enterprises:

Professor Sir Tony Kouzarides, FMedSci, FRS

 

Tony is Professor of Cancer Biology at the University of Cambridge and a Senior Group Leader at the Gurdon Institute. Tony is also the director and co-founder of the new Milner Therapeutics Institute at the University of Cambridge, which has a mission to deliver better therapies by connecting academia with industry.

READ MORE » 

Professor Tony Kouzarides, FMedSci, FRS

 

Tony is Professor of Cancer Biology at the University of Cambridge and a Senior Group Leader at the Gurdon Institute. Tony is also the director and co-founder of the new Milner Therapeutics Institute at the University of Cambridge, which has a mission to deliver better therapies by connecting academia with industry.

READ MORE » 

Selected publications:

 

• Yankova E et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature, 2021

• Barbieri I and Kouzarides T. Role of RNA modifications in cancer. Nature Reviews Cancer, 2020

• Barbieri I et al. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. Nature, 2017

READ MORE » 

The Gurdon Institute
Tennis Court Road
Cambridge, CB2 1QN
United Kingdom

Phone: +44 (0) 1223 334088
Fax: +44 (0) 1223 334089